- AU$11.95m
- AU$2.93m
- AU$7.71m
Brief: Immuron - Fy25 Global Sales Exceed Projection, Up 49% On Prior Year
Brief: Immuron Posts Global Annual Sales AUD$7.3 Million
Australia's Immuron jumps on upbeat annual sales
Brief: Immuron Travelan Highest Sales In History
Australia's Immuron gains on highest annual sales for its Travelan drug
Brief: Immuron Ltd Announces Exclusive Distribution Agreement For Australia And New Zealand
Brief: Immuron Travelan® continued strong sales growth
Brief: Immuron Announces Travelan® Clinical Trial Update
Australia's Immuron rises on positive results for Travelan Phase 2 study
Brief: Immuron Posts Quarterly Global Sales A$1.5 Million, Up 13% On Prior Quarter
Brief: Immuron Ltd Seeks Trading Halt
Brief: Immuron Plans Phase 2 Trial For Imm-529 Following FDA Review
Brief: Immuron Plans Phase 2 Trial For Imm-529 Following FDA Review
Brief: Immuron Says New US DoD Research Award To Develop Enhanced Travelan
Australia's Immuron rises on strong FY24 sales and upbeat outlook
Brief: Immuron Sees Strong North American Growth In FY25
Brief: Immuron Requests Pre-Ind Meeting For Imm-529 With FDA Filing
Brief: Immuron Says Fytd Mar 2024 Global Travelan Sales A$3.6 Million, Up 154%
Australia's Immuron jumps on increased global sales of Travelan drug